Viewing Study NCT02014727


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-05-20 @ 9:11 PM
Study NCT ID: NCT02014727
Status: COMPLETED
Last Update Posted: 2025-12-04
First Post: 2013-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: C12-18 AMA-DiCo
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER_GOV View